RAPID AND DELAYED P42/P44 MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION BY NITRIC OXIDE : THE ROLE OF CYCLIC GMP AND TYROSINE PHOSPHATASE INHIBITION

作者: Josef Pfeilschifter , Dagmar Callsen , Bernhard Brüne

DOI:

关键词:

摘要: The exposure of rat mesangial cells to cytokines promoted activation the p42/p44 mitogen-activated protein kinase (MAPK). We identified a rapid and delayed phase MAPK with distinctive activity increases at 5 15 min 24 h. Rapid late were attenuated by redox-modulating agent N -acetylcysteine. Specifically, late-phase coincided endogenous nitric oxide (NO) generation in turn was suppressed NO synthase-blocking compounds diphenyliodonium or nitroarginine methyl ester. By using NO-liberating agents such as S -nitrosoglutathione 3-morpholinosydnonimine, we investigated intermediary signaling elements promoting activation. Early transient soluble guanylyl cyclase-blocking 1 H -(1,2,4)-oxdiazolo-(4,3-α)-6-bromoquinoxazin-1-one (NS 2028) and, moreover, mimicked lipophilic cyclic GMP (cGMP) analogue 8-bromo-cGMP. In contrast, NO-mediated achieved within hours unrelated cGMP signaling. Late persistent activation, induced donors endogenously generated NO, found association inhibition phosphatase activity. vitro dephosphorylation activated immunoprecipitated cytosolic phosphatases sensitive readdition be inhibited cytosol -nitrosoglutathione-stimulated cells. Also, that had been exposed for h revealed blocked activity, which successfully synthase inhibitor ester therefore, mediated. Conclusively, affects twofold: is mediated, whereas transmitted via tyrosine dephosphorylation.

参考文章(54)
Chao-Feng Zheng, Kun-Liang Guan, None, Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues The EMBO Journal. ,vol. 13, pp. 1123- 1131 ,(1994) , 10.1002/J.1460-2075.1994.TB06361.X
G Camici, G Moneti, L Pazzagli, A Caselli, G Ramponi, G Manao, G Cappugi, Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. Journal of Biological Chemistry. ,vol. 269, pp. 24878- 24882 ,(1994) , 10.1016/S0021-9258(17)31472-2
M. Cavigelli, W. W. Li, A. Lin, B. Su, K. Yoshioka, M. Karin, The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. The EMBO Journal. ,vol. 15, pp. 6269- 6279 ,(1996) , 10.1002/J.1460-2075.1996.TB01017.X
KunLiang Guan, Jack E Dixon, None, Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. Journal of Biological Chemistry. ,vol. 266, pp. 17026- 17030 ,(1991) , 10.1016/S0021-9258(19)47335-3
R.J. Davis, The mitogen-activated protein kinase signal transduction pathway. Journal of Biological Chemistry. ,vol. 268, pp. 14553- 14556 ,(1993) , 10.1016/S0021-9258(18)82362-6
CA Dinarello, Interleukin-1 and interleukin-1 antagonism. Blood. ,vol. 77, pp. 1627- 1652 ,(1991) , 10.1182/BLOOD.V77.8.1627.1627
M.E. Ottlinger, L.A. Pukac, M.J. Karnovsky, Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. Journal of Biological Chemistry. ,vol. 268, pp. 19173- 19176 ,(1993) , 10.1016/S0021-9258(19)36492-0
Carl Nathan, Nitric oxide as a secretory product of mammalian cells. The FASEB Journal. ,vol. 6, pp. 3051- 3064 ,(1992) , 10.1096/FASEBJ.6.12.1381691
Martin Feelisch, Jonathan S. Stamler, Methods in nitric oxide research Wiley-Blackwell. ,(1996)